• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . The difference in mortality between adult patients with laboratory documented Influenza A and B, a single centre retrospective observ

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Oct 15.
doi: 10.1002/jmv.26600. Online ahead of print.
The difference in mortality between adult patients with laboratory documented Influenza A and B, a single centre retrospective observational study


Diana Ayoola Mabayoje[SUP] 1 [/SUP], Teresa Cutino-Moguel[SUP] 2 [/SUP], John Haigh[SUP] 3 [/SUP], Mark Wilks[SUP] 4 [/SUP], Catherine A Welch[SUP] 5 [/SUP], Mark Melzer[SUP] 6 [/SUP]



Affiliations

Abstract

Background: Seasonal influenza is an annual occurrence that leads to large community outbreaks and increased hospitalisation. A number of studies have suggested that influenza A (FLUAV) is associated with increased rates of hospitalisation and mortality compared to influenza B (FLUBV). This study compared demographic and clinical variables in patients diagnosed with FLUAV or FLUBV during the 2017-2018 UK Influenza season.
Methods: Patient demographic and clinical information were obtained by accessing medical records of patients testing FLUAV or FLUBV positive using the Cepheid GXP. We used χ2 test to compare variables in patients with laboratory confirmed FLUAV and FLUBV.
Results: 127 adult patients had confirmed Influenza, 71 (55.9%) had FLUAV and 56 (44.1%) FLUBV. There was no significant difference between severity at presentation, admission to HDU/ITU or median length of stay. The overall mortality was 6 (4.5%) and 9 (7.1%) at 7 and 30-days respectively. There was a statistically significant difference in 7-day mortality between patients with FLUAV and FLUBV, 1 (1.4%) vs 5 (8.9%) respectively, p= 0.047) although this became non-significant at 30-days.
Conclusions: With the exception of mortality, we did not observe significant differences between patients with FLUAV and FLUBV. 7-day mortality in patients with FLUBV was significantly higher with FLUAV, although this was was not apparent at 30 days. This article is protected by copyright. All rights reserved.

Keywords: Endemic infection; Epidemiology; Influenza virus; Mortality; Seasonal incidence
 
Back
Top Bottom